^
No biomarker
Follicular Lymphoma
axicabtagene ciloleucel
Sensitive
:
A1
No biomarker
Follicular Lymphoma
rituximab + lenalidomide
Sensitive
:
A1
No biomarker
Follicular Lymphoma
Truxima (rituximab biosimilar)
Sensitive
:
A1
No biomarker
Follicular Lymphoma
Rixathon (rituximab biosimilar)
Sensitive
:
A1
No biomarker
Follicular Lymphoma
Ruxience (rituximab biosimilar)
Sensitive
:
A1
No biomarker
Follicular Lymphoma
obinutuzumab
Sensitive
:
A1
No biomarker
Follicular Lymphoma
rituximab
Sensitive
:
A1
CD20 positive
Follicular Lymphoma
rituximab + ibritumomab tiuxetan
Sensitive
:
A1
No biomarker
Follicular Lymphoma
ibritumomab tiuxetan
Sensitive
:
A1
No biomarker
Follicular Lymphoma
idelalisib
Sensitive
:
A1
No biomarker
Follicular Lymphoma
duvelisib
Sensitive
:
A1
No biomarker
Follicular Lymphoma
tazemetostat
Sensitive
:
A1
EZH2 mutation
Follicular Lymphoma
tazemetostat
Sensitive
:
A1
No biomarker
Follicular Lymphoma
copanlisib
Sensitive
:
A1
No biomarker
Follicular Lymphoma
umbralisib
Sensitive
:
A1
No biomarker
Follicular Lymphoma
lisocabtagene maraleucel
Sensitive
:
A1
CD20 positive
Follicular Lymphoma
Ruxience (rituximab biosimilar)
Sensitive
:
A1
No biomarker
Follicular Lymphoma
R-CHOP
Sensitive
:
A2
No biomarker
Follicular Lymphoma
R-CVP
Sensitive
:
A2
No biomarker
Follicular Lymphoma
rituximab + obinutuzumab
Sensitive
:
A2
No biomarker
Follicular Lymphoma
lenalidomide
Sensitive
:
A2
No biomarker
Follicular Lymphoma
chlorambucil
Sensitive
:
A2
No biomarker
Follicular Lymphoma
lenalidomide + obinutuzumab
Sensitive
:
A2
No biomarker
Follicular Lymphoma
cyclophosphamide intravenous
Sensitive
:
A2
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our